United Therapeutics | UTHR - Operating Expenses


United Therapeutics reported $6.4B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Amarin USD 51.48M 113K Dec/2025
Ardelyx USD 127.27M 7.15M Mar/2026
Baxter International USD 2.68B 3.36B Jun/2026
Bayer EUR 10.04B 168M Jun/2026
BioCryst Pharmaceuticals USD 119.78M 673.63M Jun/2026
Biogen USD 2.98B 1.02B Jun/2026
BioMarin Pharmaceutical USD 6.32B 5.69B Jun/2026
Emergent BioSolutions USD 555.9M 242.7M Jun/2023
Gilead Sciences USD 3.95B 19.57B Jun/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
Halozyme Therapeutics USD 193.34M 1.15M Jun/2026
Insmed USD 526.79M 20.55M Jun/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
J&J USD 17.83B 388M Jun/2026
Lexicon Pharmaceuticals USD 20.27M 6.1M Dec/2025
Moderna USD 960M 817M Jun/2026
Omeros USD 59.16M 20.13M Jun/2024
Pfizer USD 85.19B 4.91B Jun/2026
PTC Therapeutics USD 226.66M 19.64M Mar/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sarepta Therapeutics USD 387.96M 15.59M Jun/2026
Teva Pharmaceutical Industries USD 3.92B 691M Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026
Vertex Pharmaceuticals USD 2.07B 217.1M Jun/2026